CLASS III Drug recall · Reported 9 Apr 2025 · FDA Enforcement Report

Tolterodine Tartrate Extended-Release Capsules, 2 mg Dose recalled

The Harvard Drug Group is recalling Tolterodine Tartrate Extended-Release Capsules, 2 mg Dose, distributed nationwide in the US. The recall was initiated on 4 Mar 2025 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot# T05393, Exp. Date: 09/30/2025
Quantity recalled224 cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0304-2025
FDA event ID
96416
Recalling firm
The Harvard Drug Group, La Vergne, TN
Classification
Class III
Status
Terminated
Recall initiated
4 Mar 2025
FDA classified
28 Mar 2025
Reported
9 Apr 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

4 Mar 2025Recall initiated by company
28 Mar 2025Classified by FDA+24 days
9 Apr 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.

Which lots are affected?

Lot# T05393, Exp. Date: 09/30/2025

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from The Harvard Drug Group

All 79

Other Tolterodine recalls

All 4